Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Fermiscan
New Australian Technology: Detecting Breast Cancer With Hair
July 1st, 2008
The Australian company Fermiscan, who is using a US synchrotron in the development of a new breast cancer screening test through the analysis of an individual's hair, has demonstrated an accuracy rate of 69% in detecting breast cancer. A recent study published in the Journal of the American Medical Association(1) (US study), showed that breast screening using either mammography or ultrasound achieved no greater than a 50% sensitivity at detecting breast cancer. A sensitivity of 78% was achieved when techniques were combined. Fermiscan recently completed a similarly sized clinical trial(2) designed to compare results from current screening methods of mammography,...
Source: Cancer Weekly (2008-07-01)
|
